Ignite Creation Date:
2024-05-06 @ 9:28 AM
Last Modification Date:
2024-10-26 @ 12:15 PM
Study NCT ID:
NCT02995655
Status:
COMPLETED
Last Update Posted:
2019-12-05
First Post:
2016-12-13
Brief Title:
CX-01 Combined With Azacitidine in the Treatment of Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
Sponsor:
Washington University School of Medicine
Organization:
Washington University School of Medicine
Organization Data
Organization:
Washington University School of Medicine
Class:
OTHER
Study ID:
201608032
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Washington University School of Medicine
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Cantex Pharmaceuticals | INDUSTRY |